Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Maceron Jul 18, 2019 11:53am

137 Views

Post# 29934887

RE:RE:RE:RE:RE:NEWS (No Event Worth Speakingabout)

enriquesuave wrote: Could it be that patient or patients have been treated, but just waiting on 7 days initial safety time point to pass before PMH makes an announcement? I hope so, but sooner or later we will hear something.

Not worried at all about enrollement at PMH. They are approved and ready to go. We can expect the same pace of enrollement as phase 1 from PMH.
I am interested in bring on more sites, this will be a catalyst.
FDA application should be a significant boost. Approval and site enrollement in the US will be music to our ears.
If they could only use the laser to treat the cancer in the oval office!
Macer

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading